T+3 sellers really mucked up the market mid-week, now stablizing.
This vehicle has its source of funding in place (teva pharma) should the trials be successful. I would have thought in the current environment that is a very significant event, deserving a substantial rerate in the stock-price.....
T+3 sellers really mucked up the market mid-week, now...
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PER (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
10.0¢ |
Change
-0.005(4.76%) |
Mkt cap ! $90.15M | |||
| Open | High | Low | Value | Volume |
| 11.0¢ | 11.0¢ | 10.0¢ | $54.97K | 528.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 396468 | 10.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 10.5¢ | 99708 | 1 |
View Market Depth
| Last trade - 16.10pm 01/10/2024 (20 minute delay) ? |
| PER (ASX) Chart |